XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating Expenses:        
Research and development $ 3,773 $ 11,392 $ 26,040 $ 33,522
General and administrative 2,602 3,071 8,088 9,721
Total operating expenses 6,375 14,463 34,128 43,243
Loss from operations (6,375) (14,463) (34,128) (43,243)
Other income (expense):        
Grant income 1,215 4,293 13,407 16,516
Other income, net 230 236 585 813
Interest expense   (3) (8) (20)
Loss on currency translation from liquidation of subsidiary       (195)
Total other income, net 1,445 4,526 13,984 17,114
Net loss (4,930) (9,937) (20,144) (26,129)
Foreign currency translation adjustment, including reclassifications       195
Total comprehensive loss $ (4,930) $ (9,937) $ (20,144) $ (25,934)
Net loss per share, basic (in dollars per share) $ (0.06) $ (0.25) $ (0.3) $ (0.69)
Net loss per share, diluted (in dollars per share) $ (0.06) $ (0.25) $ (0.3) $ (0.69)
Weighted-average common shares outstanding, basic (in shares) 77,951,513 40,418,065 67,488,145 38,080,658
Weighted-average common shares outstanding, diluted (in shares) 77,951,513 40,418,065 67,488,145 38,080,658